In vivo Distribution and Metabolism of Calcium Phosphate Nanomaterials Based on Fluorescent Labeling with Rare Earth Europium Ions
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Lanthanide and Transition Metal Complexes · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. SOKOLOVA V, EPPLE M. Biological and medical applications of calcium phosphate nanoparticles. Chemistry - A European Journal, 2021, 27(27): 7471.10.1002/chem.202005257 ↗
2. LI B, XU W F, LIAO X L. Research progress in calcium phosphate microspheres for bone defect repair. Journal of Inorganic Materials, 2014, 29(10): 1009.10.15541/jim20140010 ↗
3. CHEN X, LI H Z, MA Y H, et al. Calcium phosphate-based nanomaterials: preparation, multifunction, and application for bone tissue engineering. Molecules, 2023, 28(12): 4790.10.3390/molecules28124790 ↗
4. NIE L, HOU M J, WANG T W, et al. Nanostructured selenium- doped biphasic calcium phosphate with in situ incorporation of silver for antibacterial applications. Scientific Reports, 2020, 10: 13738.10.1038/s41598-020-70776-7 ↗
5. 刘静霆, 韩颖超, 李世普, 等. 羟基磷灰石纳米粒子负载阿霉素的体外抗肿瘤活性研究. 中国生物医学工程学报, 2008, 27(4): 572.
6. CHEN F, HUANG P, ZHU Y J, et al. Multifunctional Eu3+/Gd3+ dual-doped calcium phosphate vesicle-like nanospheres for sustained drug release and imaging. Biomaterials, 2012, 33(27): 6447.10.1016/j.biomaterials.2012.05.059 ↗
7. LI C Y, DING Z Y, HAN Y C. In vitro antibacterial and osteogenic properties of manganese doped nano hydroxyapatite. Journal of Inorganic Materials, 2024, 39(3): 313.10.15541/jim20230438 ↗
8. LI C Y, DING Z Y, HAN Y C. Mn-doped nano-hydroxyapatites as theranostic agents with tumor pH-amplified MRI-signal capabilities for guiding photothermal therapy. International Journal of Nanomedicine, 2023, 18: 6101.10.2147/IJN.S429336 ↗
9. JACOBS A, RENAUDIN G, CHARBONNEL N, et al. Copper- doped biphasic calcium phosphate powders: dopant release, cytotoxicity and antibacterial properties. Materials, 2021, 14(9): 2393.10.3390/ma14092393 ↗
10. ZHAO R B, REN X Y, XIE C G, et al. Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles. Microscopy Research and Technique, 2017, 80(3): 321.10.1002/jemt.22800 ↗
11. KOLLENDA S A, KLOSE J, KNUSCHKE T, et al. In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT. Acta Biomaterialia, 2020, 109: 244.10.1016/j.actbio.2020.03.031 ↗
12. ADAMIANO A, IAFISCO M, SANDRI M, et al. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging. Acta Biomaterialia, 2018, 73: 458.10.1016/j.actbio.2018.04.040 ↗
13. ÁLAMO P, PALLARÈS V, CÉSPEDES M V, et al. Fluorescent dye labeling changes the biodistribution of tumor-targeted nanoparticles. Pharmaceutics, 2020, 12(11): 1004.10.3390/pharmaceutics12111004 ↗
14. ALTINOǦLU E I, RUSSIN T J, KAISER J M, et al. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano, 2008, 2(10): 2075.10.1021/nn800448r ↗
15. LLOP J, GÓMEZ-VALLEJO V, GIBSON N. Quantitative determination of the biodistribution of nanoparticles: could radiolabeling be the answer? Nanomedicine, 2013, 8(7): 1035.10.2217/nnm.13.91 ↗
16. JEONG H J, LEE B C, AHN B C, et al. Development of drugs and technology for radiation theragnosis. Nuclear Engineering and Technology, 2016, 48(3): 597.10.1016/j.net.2016.04.003 ↗
17. LI P Z, WANG D D, HU J, et al. The role of imaging in targeted delivery of nanomedicine for cancer therapy. Advanced Drug Delivery Reviews, 2022, 189: 114447.10.1016/j.addr.2022.114447 ↗
18. WANG T T, ZHANG D, SUN D, et al. Current status of in vivo bioanalysis of nano drug delivery systems. Journal of Pharmaceutical Analysis, 2020, 10(3): 221.10.1016/j.jpha.2020.05.002 ↗
19. XIE Y F, PERERA T S H, LI F, et al. Quantitative detection method of hydroxyapatite nanoparticles based on Eu3+ fluorescent labeling in vitro and in vivo. ACS Applied Materials & Interfaces, 2015, 7(43): 23819.10.1021/acsami.5b08767 ↗
20. HAN Y C,XING Q G, WANG X Y. Quantitative detection method of rare earth doped calcium phosphate fluorescent nanometer particles in organisms: US921123B2. 2024-03-05.
21. DING Z Y, XING Q G, FAN Y R, et al. Polyacrylic acid complexes to mineralize ultrasmall europium-doped calcium phosphate nanodots for fluorescent bioimaging. Materials & Design, 2022, 221: 111008.10.1016/j.matdes.2022.111008 ↗
22. LE A D, WEARING H J, LI D S. Streamlining physiologically- based pharmacokinetic model design for intravenous delivery of nanoparticle drugs. CPT: Pharmacometrics & Systems Pharmacology, 2022, 11(4): 409.10.1002/psp4.12762 ↗
23. DENG L J, LIU H, MA Y S, et al. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles. Toxicology and Applied Pharmacology, 2019, 384: 114765.10.1016/j.taap.2019.114765 ↗
24. LI M, ZOU P, TYNER K, et al. Physiologically based pharmacokinetic (PBPK) modeling of pharmaceutical nanoparticles. The AAPS Journal, 2017, 19(1): 26.10.1208/s12248-016-0010-3 ↗
25. CHENG Y H, HE C L, RIVIERE J E, et al. Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach. ACS Nano, 2020, 14(3): 3075.10.1021/acsnano.9b08142 ↗
26. ZHANG S Q, MA X Y, SHA D Y, et al. A novel strategy for tumor therapy: targeted, PAA-functionalized nano-hydroxyapatite nanomedicine. Journal of Materials Chemistry B, 2020, 8(41): 9589.10.1039/D0TB01603A ↗
27. CHENG X, XU Y R, ZHANG Y, et al. Glucose-targeted hydroxyapatite/indocyanine green hybrid nanoparticles for collaborative tumor therapy. ACS Applied Materials & Interfaces, 2021, 13(31): 37665.10.1021/acsami.1c09852 ↗
28. BERNIER A, TOBIAS T, NGUYEN H, et al. Vascular and blood compatibility of engineered cationic cellulose nanocrystals in cell-based assays. Nanomaterials, 2021, 11(8): 2072.10.3390/nano11082072 ↗
29. SREENIVASAGAN S, SUBRAMANIAN A K, MOHANRAJ K G, et al. Assessment of toxicity of green synthesized silver nanoparticle-coated titanium mini-implants with uncoated mini- implants: comparison in an animal model study. The Journal of Contemporary Dental Practice, 2024, 24(12): 944.10.5005/jp-journals-10024-3577 ↗
30. 高绪聪, 柴振海, 张宗鹏. 药物性肝损伤的生物标志物及其评价的研究进展. 中国药理学与毒理学杂志, 2012, 26(5): 692.
31. KASHANI K, ROSNER M H, OSTERMANN M. Creatinine: from physiology to clinical application. European Journal of Internal Medicine, 2020, 72: 9.10.1016/j.ejim.2019.10.025 ↗
32. ALMEIDA J P M, CHEN A L, FOSTER A, et al. In vivo biodistribution of nanoparticles. Nanomedicine, 2011, 6(5): 815.10.2217/nnm.11.79 ↗
33. 祁禹鸣, 徐铭泽, 杜步婕. 纳米材料在肾脏中的应用与清除机制. 广州医药, 2023, 54(1): 1.
34. CHOI J S, CAO J F, NAEEM M, et al. Size-controlled biodegradable nanoparticles: preparation and size-dependent cellular uptake and tumor cell growth inhibition. Colloids and Surfaces B: Biointerfaces, 2014, 122: 545.10.1016/j.colsurfb.2014.07.030 ↗
35. LEDFORD B T, WYATT T G, VANG J, et al. Effects of particle size, charge, shape, animal disease state, and sex on the biodistribution of intravenously administered nanoparticles. Particle & Particle Systems Characterization, 2023, 40(7): 2300001.10.1002/ppsc.202300001 ↗
36. MELLOR R D, UCHEGBU I F. Ultrasmall-in-nano: why size matters. Nanomaterials, 2022, 12(14): 2476.10.3390/nano12142476 ↗
37. WEI Y C, QUAN L, ZHOU C, et al. Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application. Nanomedicine, 2018, 13(12): 1495.10.2217/nnm-2018-0040 ↗
38. TANG L, YANG X J, YIN Q, et al. Investigating the optimal size of anticancer nanomedicine. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(43): 15344.10.1073/pnas.1411499111 ↗
39. WANG J, LIU G. Imaging nano-bio interactions in the kidney: toward a better understanding of nanoparticle clearance. Angewandte Chemie International Edition, 2018, 57(12): 3008.10.1002/anie.201711705 ↗
40. ZHAO Y T, WANG Y, RAN F, et al. A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Scientific Reports, 2017, 7: 4131.10.1038/s41598-017-03834-2 ↗
41. 董立乐.几种硫属及稀土纳米材料的制备与癌症诊疗探索. 合肥: 中国科学技术大学博士学位论文, 2019.